The Parkinson’s Foundation and the American College of Sports Medicine (ACSM) are teaming up to make exercise more accessible and…
Articles by Andrea Lobo
A Phase 1b clinical trial evaluating Serina Therapeutics’s SER-252 (POZ-apomorphine) in people with advanced Parkinson’s disease has enrolled its…
Depression that starts later in life could be an early clinical manifestation of Parkinson’s disease and the related condition…
Targeting a brain network that links thinking and movement may be an effective treatment strategy for easing motor symptoms in…
Merz Therapeutics North America has launched “Celebrating the Fighters,” a nationwide U.S. community campaign honoring the resiliency and courage…
Boston University has been awarded a $2 million research grant from The Michael J. Fox Foundation for Parkinson’s Research…
Researchers at Case Western Reserve University in Cleveland, Ohio, developed a new compound that blocks a harmful interaction between the…
A clinical trial testing Teitur Trophics‘ TT-P34 in Parkinson’s disease will use Neuralight‘s brain function biomarker based on…
A team at Michigan State University (MSU) won two grants to support research into portable devices designed to improve communication…
Light therapy using Celeste, Photopharmics’ investigational photo-neuromodulation device, was seen in a clinical trial to ease nonmotor symptoms in…